Physician profile
John T Morris
NPI 1982819611
$2,921.02
in general payments reported to CMS, 2019-2025
11 companies · $488 in 2025
The $488 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $134 · 2021: $179 · 2022: $1,360 · 2023: $246 · 2024: $72.11 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $806.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,288.55 | 2022 | |
| W. L. Gore & Associates, INC. | $1,011.24 | 2019-2025 | Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, C3 Delivery System |
| Penumbra, INC. | $171.00 | 2025 | Penumbra System |
| Cook Medical LLC | $117.39 | 2019-2021 | |
| Organogenesis INC. | $111.30 | 2019 | |
| Ekos Corporation | $92.00 | 2019 | |
| Medtronic Vascular, INC. | $48.95 | 2019 | |
| Urgo Medical North America, LLC | $25.84 | 2023 | Urgok2 |
| Bioventus LLC | $20.67 | 2023 | |
| Bsn Medical INC | $20.11 | 2024 | |
| Avenu Medical INC. | $13.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.